Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo

This publication has 40 references indexed in Scilit:

• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
  The Lancet, 2012
• Tumor delivery of macromolecular drugs based on the EPR effect
  Advanced Drug Delivery Reviews, 2011
• The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion
  Biomaterials, 2010
• Aptamers as therapeutics
  Nature Reviews Drug Discovery, 2010
• Aptamers for Targeted Drug Delivery
  Pharmaceuticals, 2010
• The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
  British Journal of Cancer, 2008
• Nanotechnology and aptamers: applications in drug delivery
  Trends in Biotechnology, 2008
• Synthesis of selenium nanoparticles in the presence of silk fibroin
  Materials Letters, 2007
• Breast cancer metastasis: markers and models
  Nature Reviews Cancer, 2005
• Interaction of the anticancer drug epirubicin with DNA
  Analytica Chimica Acta, 2001